ARCHIVES

NCI Cooperative Group Clinical Trials Approved

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

Upton Considers Moving Basic Research Contracts To grants; Staff Changes Possible, Newell Stay

July 22, 1977

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

Avastin Improves PFS For Metastatic Colorectal Cancer In Phase III Study

February 23, 2007